Moderna Stock Price on August 13, 2022 Breakdown

MRNA
 Stock
  

USD 118.25  0.18  0.15%   

As of today, the current price of Moderna is  118.25 , as last reported on the 30th of September, with the highest price reaching  122.58  and the lowest price hitting  118.09  during the day.
Moderna has Sharpe Ratio of -0.0929, which conveys that the firm had -0.0929% of return per unit of risk over the last 3 months. Macroaxis standpoint towards estimating the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Moderna exposes twenty-eight different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to verify Moderna mean deviation of 2.83, and Risk Adjusted Performance of (0.05) to check out the risk estimate we provide.
  

Moderna Main Headline on 10th of August 2022

With Growth Slowing, Is Moderna Stock Still Worth A Look Forbes

Moderna Valuation on August 13, 2022

It is possible to determine the worth of Moderna on a given historical date. On August 13, 2022 Moderna was worth 174.09 at the beginning of the trading date compared to the closed value of 174.27. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Moderna stock. Still, in general, we apply an absolute valuation method to find Moderna's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Visa where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Moderna's related companies.
 Open High Low Close Volume
  176.01    180.71    169.20    171.14    5,082,500  
08/10/2022
  174.09    176.68    169.82    174.27    3,550,300  
  174.43    179.85    171.06    171.81    3,340,500  
Backtest Moderna  |  Moderna History  |  Moderna Valuation   PreviousNext  
Open Value 174.09
162.42
Downside
174.27
Closing Value
185.76
Upside

Moderna Trading Date Momentum on August 13, 2022

On August 11 2022 Moderna was traded for  171.81  at the closing time. The top price for the day was 179.85  and the lowest listed price was  171.06 . The trading volume for the day was 3.3 M. The trading history from August 11, 2022 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.41% . The trading delta at closing time against the current closing price is 16.65% .

Moderna Fundamentals Correlations and Trends

By evaluating Moderna's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Moderna's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Moderna financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Moderna Stock history

Moderna investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Moderna is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Moderna will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Moderna historical stock prices may prove useful in developing a viable investing in Moderna
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPVPIV3 vaccines latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines intratumoral immuno-oncology products localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC Merck Co., Inc. Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Limited Carisma Therapeutics, Inc. Metagenomi, Inc. the Defense Advanced Research Projects Agency Biomedical Advanced Research and Development Authority Institute for Life Changing Medicines and The Bill Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Moderna Stock Technical Analysis

Moderna technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Moderna technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Moderna trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Moderna Period Price Range

Low
August 10, 2022
High

 174.09 

  

 174.27 

0.180.10%

Moderna September 30, 2022 Market Strength

Market strength indicators help investors to evaluate how Moderna stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Moderna shares will generate the highest return on investment. By undertsting and applying Moderna stock market strength indicators, traders can identify Moderna entry and exit signals to maximize returns

Moderna Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Moderna stock's direction in advance. Along with the technical and fundamental analysis of Moderna Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Moderna to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen stock market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Additionally, see Correlation Analysis. You can also try Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for analysis

When running Moderna price analysis, check to measure Moderna's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moderna is operating at the current time. Most of Moderna's value examination focuses on studying past and present price action to predict the probability of Moderna's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Moderna's price. Additionally, you may evaluate how the addition of Moderna to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Is Moderna's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Moderna. If investors know Moderna will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Moderna listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Moderna is measured differently than its book value, which is the value of Moderna that is recorded on the company's balance sheet. Investors also form their own opinion of Moderna's value that differs from its market value or its book value, called intrinsic value, which is Moderna's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Moderna's market value can be influenced by many factors that don't directly affect Moderna's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Moderna's value and its price as these two are different measures arrived at by different means. Investors typically determine Moderna value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Moderna's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.